Jakimovski, Dejan
Awan, Samreen
Eckert, Svetlana P.
Farooq, Osman
Weinstock-Guttman, Bianca http://orcid.org/0000-0001-6732-151X
Article History
Accepted: 2 December 2021
First Online: 23 December 2021
Declarations
:
: The Authors have not received any direct funding that is associated with this manuscript.
: Dejan Jakimovski, Samreen Awan, Svetlana P. Eckert, and Osman Farooq have nothing to disclose. Dr Bianca Weinstock-Guttman has participated in speaker's bureaus and/or served as a consultant for Biogen, EMD Serono, Novartis, Genentech, Celgene/Bristol Meyers Squibb, Sanofi Genzyme, Bayer, Janssen, and Horizon. Dr Weinstock-Guttman also has received grant/research support from the agencies listed in the previous sentence. She serves on the editorial board for BMJ Neurology, Children, CNS Drugs, MS International, and Frontiers Epidemiology.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors have contributed to drafting and reviewing of the manuscript. All authors approved the final version of the manuscript and agree to be accountable for the work presented in the manuscript.
Free to read: This content has been made available to all.